{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T12:24:46Z","timestamp":1768825486649,"version":"3.49.0"},"reference-count":0,"publisher":"Portico","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2019.55.12.3078389","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T11:09:29Z","timestamp":1577790569000},"page":"727","source":"Crossref","is-referenced-by-count":4,"title":["Tafamidis: a selective transthyretin stabilizer to treat wild-type\nATTR amyloidosis and hereditary ATTR amyloidosis with\ncardiomyopathy"],"prefix":"10.3730","volume":"55","author":[{"family":"Paton, D.M.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2019]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:11:09Z","timestamp":1685452269000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddbgh4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2019.55.12.3078389","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}